Home Newsfeeds Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Baird analyst Michael Halloran downgrades Evoqua Water Techs (NYSE:AQUA) from Outperform to Neutral and maintains $49 price target.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Baird analyst Michael Halloran downgrades Evoqua Water Techs (NYSE:AQUA) from Outperform to Neutral and maintains $49 price target.

Analyst Ratings

Demystifying Webster Finl: Insights From 7 Analyst Reviews

By Benzinga Insights

April 24, 11:00 AM

7 analysts have expressed a variety of opinions on Webster Finl (NYSE:WBS) over the past quarter, offering a…

WBS

Northland Capital Markets Maintains Outperform on Sangoma Technologies, Lowers Price Target to $13

By Benzinga Newsdesk

February 13, 9:38 AM

Northland Capital Markets analyst Michael Latimore maintains Sangoma Technologies (NASDAQ:SANG) with a Outperform and lowers the price target from $15 to $13.

SANG

US Transport Department Slaps $1.5M Fine On Emirates For Operating Flights In Restricted Airspace With JetBlue Code

By Benzinga Neuro

June 14, 8:47 AM

These flights, carrying JetBlue's code, were operated in airspace that the Federal Aviation Administration (FAA) had restricted to U.S. operators.

JBLU

Veracyte, Inc. Announces Study Published In JNCI Cancer Spectrum Demonstrates Real-World Utility Of Co’s Decipher Prostate Genomic Classifier In Prostate Cancer Treatment

By Happy Mohamed

Yesterday, 8:18 AM

Clinical utility study findings based on analysis of the National Cancer Institute's SEER database Veracyte, Inc. (NASDAQ:VCYT) announced the publication of a large, real-world study reinforcing the Decipher

VCYT

Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Related Posts

Demystifying Webster Finl: Insights From 7 Analyst Reviews

Northland Capital Markets Maintains Outperform on Sangoma Technologies, Lowers Price Target to $13

US Transport Department Slaps $1.5M Fine On Emirates For Operating Flights In Restricted Airspace With JetBlue Code

Veracyte, Inc. Announces Study Published In JNCI Cancer Spectrum Demonstrates Real-World Utility Of Co’s Decipher Prostate Genomic Classifier In Prostate Cancer Treatment